v3.19.2
Organization and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Schedule of potential common shares of anti-dilutive

For the Six Months Ended June 30,  2019  2018
Shares Issuable Upon Exercise of Outstanding Warrants - Series RX-2   98,131,600    —   
Shares Issuable Upon Exercise of Outstanding Warrants - Series RX-3   481,212,000    —   
Shares Issuable Upon Conversion of Outstanding Convertible Note Payables   —      280,003,944 
     Total weighted average anti-dilutive potential common shares   579,343,600    280,003,944 
Schedule of dilutive potential common shares

   For the Three Months Ended June 30,  For the Six Months Ended June 30,
   2019  2018  2019  2018
Weighted-average Common Shares   718,327,650    533,851,417    716,646,072    532,527,107 
Effect of Dilutive Securities:                    
     Weighted-average of Shares Issuable Upon Conversion of Preferred Stock Series RX-1   28,060,516    —      14,107,773    —   
Dilutive Potential Common Shares   746,388,166    533,851,417    730,753,846    532,527,107